Accredited Investors Inc. Abb Vie Inc. Transaction History

Accredited Investors Inc.

$1.55 Billion
Q2 2024

A detailed history of Accredited Investors Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Accredited Investors Inc. holds 6,686 shares of ABBV stock, worth $1.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,686

Previous 6,782 1.42%

Holding current value

$1.3 Million

Previous $1.24 Million 7.21%

% of portfolio

0.07%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $14,859 - $17,352	-96 Reduced 1.42%	6,686 $1.15 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $17,260 - $19,666	-108 Reduced 1.57%	6,782 $1.24 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $42,518 - $47,885	-309 Reduced 4.29%	6,890 $1.07 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $56,642 - $65,571	424 Added 6.26%	7,199 $1.07 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $30,212 - $37,597	-228 Reduced 3.26%	6,775 $912,000
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $5,495 - $6,328	-38 Reduced 0.54%	7,003 $1.12 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $89,071 - $106,820	644 Added 10.07%	7,041 $1.14 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $65,897 - $75,579	491 Added 8.31%	6,397 $859,000
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $7,706 - $9,797	56 Added 0.96%	5,906 $905,000
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $24,548 - $30,457	186 Added 3.28%	5,850 $948,000
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $68,970 - $87,267	-642 Reduced 10.18%	5,664 $767,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $41,708 - $47,345	392 Added 6.63%	6,306 $680,000
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $1,998 - $2,226	19 Added 0.32%	5,914 $666,000
Q1 2021 Apr 16, 2021	SELL	$102.3 - $112.62 $13,401 - $14,753	-131 Reduced 2.17%	5,895 $638,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $2,978 - $4,020	37 Added 0.62%	6,026 $646,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $1,540 - $2,061	21 Added 0.35%	5,989 $588,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $2,838 - $4,302	44 Added 0.74%	5,968 $455,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $12,262 - $15,342	170 Added 2.95%	5,924 $525,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $29,915 - $35,967	-475 Reduced 7.63%	5,754 $436,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1,379 - $1,763	21 Added 0.34%	6,229 $0
Q1 2019 Apr 17, 2019	BUY	$77.14 - $90.79 $41,424 - $48,754	537 Added 9.47%	6,208 $500,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $126,506 - $156,016	1,625 Added 40.16%	5,671 $523,000
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $32,096 - $35,681	361 Added 9.8%	4,046 $383,000
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $7,810 - $9,242	87 Added 2.42%	3,685 $341,000
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $460 - $616	5 Added 0.14%	3,598 $341,000
Q4 2017 Jan 17, 2018	BUY	$89.56 - $98.21 $64,483 - $70,711	720 Added 25.06%	3,593 $348,000
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $200,679 - $256,329	2,873	2,873 $255,000

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Account

Accredited Investors Inc. Abb Vie Inc. Transaction History